Antibacterial and antiviral potential of neuropeptides

Submitted: 28 February 2019
Accepted: 13 March 2019
Published: 13 May 2019
Abstract Views: 1744
PDF: 518
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The emergence of multidrug resistant bacteria is a global health threat and the discovery of new antimicrobial agents is an absolute priority. In this context endogenous peptides are emerging as novel potential candidates. In this work, we assessed the antimicrobial effects of orexins and ghrelin neuropeptides against gram-negative (Escherichia coli, Salmonella typhimurium, Klebsiella pneumoniae) and gram-positive (Staphylococcus aureus) bacteria. Orexin-B and ghrelin showed a potent bactericidal effect at concentration equal to or greater than 25 μg/ml. No antimicrobial activity has been observed for orexin-A. Furthermore, we investigated the antiviral proprieties of the three peptides against herpes simplex virus 1 (HSV-1). We found that orexin-B, but not orexin-A is effective for HSV-1 infectivity inhibition.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Zannella, C., Stelitano, D., Folliero, V., Palomba, L., Bovier, T. F., Astorri, R., Chianese, A., Monda, M., Galdiero, M., & Franci, G. (2019). Antibacterial and antiviral potential of neuropeptides. Translational Medicine Reports, 3(1). https://doi.org/10.4081/tmr.8142